Seaspine Orthopedics Corporation recalls SeaSpine Polyaxial Head
The stated reason: Due to manufacturing error, polyaxial head may popoff from the screw intraoperatively following insertion.
Seaspine Orthopedics Corporation began a medical device recall on May 28, 2026 whose reported distribution included Ohio. FDA
What the record shows
FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 796 units. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: May 28, 2026 FDA
- Recall number: Z-2762-2026 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Seaspine Orthopedics Corporation FDA
- Product: SeaSpine Polyaxial Head REF Number: 41-3010 FDA
- Reason for recall: Due to manufacturing error, polyaxial head may popoff from the screw intraoperatively following insertion. FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | Z-2762-2026 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Seaspine Orthopedics Corporation |
| Product | SeaSpine Polyaxial Head REF Number: 41-3010 |
| Reason for recall | Due to manufacturing error, polyaxial head may popoff from the screw intraoperatively following insertion. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | 796 units |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20260528 |
| Reported | 20260729 |
| Distribution | Worldwide - US Nationwide distribution including in the states of Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana, Kansas, Maryland, Michigan, Missouri, Mississippi, Montana, Nevada, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, and Wyoming. The countries of Chile and Australia. |
| Firm location | Carlsbad, CA, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.